Powder: -20°C for 3 years | In solvent: -80°C for 1 year
5-trans-Prostaglandin E2 accelerates fibrinolysis by enhancing plasminogen activation mediated by tissue-type plasminogen activator. It also inhibits platelet aggregation in human PRP.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 180.00 | |
5 mg | 35 days | $ 798.00 | |
10 mg | 35 days | $ 1,410.00 |
Description | 5-trans-Prostaglandin E2 accelerates fibrinolysis by enhancing plasminogen activation mediated by tissue-type plasminogen activator. It also inhibits platelet aggregation in human PRP. |
Molecular Weight | 352.47 |
Formula | C20H32O5 |
CAS No. | 36150-00-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
5-trans-Prostaglandin E2 36150-00-2 inhibitor inhibit